Comparison of two methods of collecting induced sputum in asthmatic subjects

The method that we have previously reported for sputum induction involves collecting the entire expectorate produced over a 20 min inhalation of 3% saline aerosol. This method presents the potential disadvantage of a considerable and variable salivary contribution to the induced sputum sample. In this study, we examined whether separate collection of saliva and sputum represents a better method for collecting induced sputum during sputum induction. In 11 stable asthmatics, we compared the volume, total and differential cell counts, and eosinophil cationic protein (ECP) levels in four induced sputum samples, two performed using our previous method (Method A) and two using another method (Method B) in which subjects spit saliva into one container before coughing sputum into another. We found that the volume of sputum obtained with Method B was lower than that obtained with Method A (6.16 +/- 0.61 vs 20.1 +/- 2.7 mL; p = 0.003), as was the percentage of squamous cells (34 +/- 4 vs 47 +/- 6; p = 0.023). In addition, the ECP levels in samples collected by Method B were higher (261 +/- 42 vs 145 +/- 26 ng.mL-1; p = 0.01). The differential counts of nonsquamous cells were similar except for the percentage of neutrophils, which was lower in Method B (37 +/- 4 vs 50 +/- 5%; p = 0.019). The repeatability of measurements of eosinophil percentages and of ECP levels was similar for the two methods. We conclude that separate collection of saliva and sputum yields induced sputum samples with reduced amounts of saliva and is, therefore, a better method for collecting induced sputum.

This article has been cited by other articles:

				A. L. Innes, S. D. Carrington, D. J. Thornton, S. Kirkham, K. Rousseau, R. H. Dougherty, W. W. Raymond, G. H. Caughey, S. J. Muller, and J. V. Fahy Ex Vivo Sputum Analysis Reveals Impairment of Protease-dependent Mucus Degradation by Plasma Proteins in Acute Asthma Am. J. Respir. Crit. Care Med., August 1, 2009; 180(3): 203 - 210. [Abstract] [Full Text] [PDF]

				B. L Schulz, A. J Sloane, L. J Robinson, S. S Prasad, R. A Lindner, M. Robinson, P. T Bye, D. W Nielson, J. L Harry, N. H Packer, et al. Glycosylation of sputum mucins is altered in cystic fibrosis patients Glycobiology, July 1, 2007; 17(7): 698 - 712. [Abstract] [Full Text] [PDF]

				H. van der Vaart, D. S. Postma, W. Timens, H. F. Kauffman, M. N. Hylkema, and N. H.T. ten Hacken Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. Chest, October 1, 2006; 130(4): 1157 - 1164. [Abstract] [Full Text] [PDF]

				M. Akpinar-Elci, K. J. Stemple, P. L. Enright, J. V. Fahy, T. A. Bledsoe, K. Kreiss, and D. N. Weissman Induced Sputum Evaluation in Microwave Popcorn Production Workers Chest, August 1, 2005; 128(2): 991 - 997. [Abstract] [Full Text] [PDF]

				M. Arjomandi, I. Schmidlin, P. Girling, K. Boylen, R. Ferrando, and J. Balmes Sputum Induction and Bronchoscopy for Assessment of Ozone-Induced Airway Inflammation in Asthma Chest, July 1, 2005; 128(1): 416 - 423. [Abstract] [Full Text] [PDF]

				J.L. Simpson, N.L. Timmins, K. Fakes, P.I. Talbot, and P.G. Gibson Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels Eur. Respir. J., May 1, 2004; 23(5): 759 - 762. [Abstract] [Full Text] [PDF]

				R.O. Crapo, R.L. Jensen, and F.E. Hargreave Airway inflammation in COPD: physiological outcome measures and induced sputum Eur. Respir. J., June 1, 2003; 21(41_suppl): 19S - 28s. [Abstract] [Full Text] [PDF]

				Leader of the Working Group: P.L. Paggiaro, Members of the Working Group:, P. Chanez, O. Holz, P.W. Ind, R. Djukanovic, P. Maestrelli, and P.J. Sterk Sputum induction Eur. Respir. J., July 1, 2002; 20(37_suppl): 3S - 8s. [Full Text] [PDF]

				Leader of the Working Group: A. Efthimiadis, A. Sp, Members of the Working Group:, Q. Hamid, M.M. Kelly, M. Linden, R. Louis, M.M.M. Pizzichini, E. Pizzichini, C. Ronchi, F. Van Overveld, et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation Eur. Respir. J., July 1, 2002; 20(37_suppl): 19S - 23s. [Full Text] [PDF]

				J. V. FAHY, H. A. BOUSHEY, S. C. LAZARUS, E. A. MAUGER, R. M. CHERNIACK, V. M. CHINCHILLI, T. J. CRAIG, J. M. DRAZEN, J. G. FORD, J. E. FISH, et al. Safety and Reproducibility of Sputum Induction in Asthmatic Subjects in a Multicenter Study Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1470 - 1475. [Abstract] [Full Text]

				H. Gong Jr., W. S. Linn, S. L. Terrell, K. R. Anderson, and K. W. Clark Anti-inflammatory and Lung Function Effects of Montelukast in Asthmatic Volunteers Exposed to Sulfur Dioxide Chest, February 1, 2001; 119(2): 402 - 408. [Abstract] [Full Text] [PDF]

				C. L. ORDOÑEZ, R. KHASHAYAR, H. H. WONG, R. FERRANDO, R. WU, D. M. HYDE, J. A. HOTCHKISS, Y. ZHANG, A. NOVIKOV, G. DOLGANOV, et al. Mild and Moderate Asthma Is Associated with Airway Goblet Cell Hyperplasia and Abnormalities in Mucin Gene Expression Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 517 - 523. [Abstract] [Full Text]

				A. B. Nia, L. M. Maas, S. G. J. Van Breda, D. M. J. Curfs, J. C. S. Kleinjans, E. F. M. Wouters, and F. J. Van Schooten Applicability of Induced Sputum for Molecular Dosimetry of Exposure to Inhalatory Carcinogens: 32P-Postlabeling of Lipophilic DNA Adducts in Smokers and Nonsmokers Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 367 - 372. [Abstract] [Full Text]

				A. Jatakanon, S. Kharitonov, S. Lim, and P. J Barnes Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma Thorax, February 1, 1999; 54(2): 108 - 114. [Abstract] [Full Text]